References
- No authors listedSecondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study GroupLancet19933428882125512627901582
- No authors listedWarfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II StudyLancet199434388996876917907677
- HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHPInterventions to enhance medication adherenceCochrane Database Syst Rev20054CD00001116235271
- FangMCGoASChangYWarfarin discontinuation after starting warfarin for atrial fibrillationCirc Cardiovasc Qual Outcomes20103662463120959565
- EwenSRettig-EwenVMahfoudFBöhmMLaufsUDrug adherence in patients taking oral anticoagulation therapyClin Res Cardiol2014103317318223999974
- ConnollySJEzekowitzMDYusufSEikelboomJOldgrenJParekhADabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361191139115119717844
- PatelMRMahaffeyKWGargJRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
- GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
- GiuglianoRPRuffCTBraunwaldEEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
- LiewAEikelboomJWO’DonnellMRandomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillationCurr Opin Cardiol201227433133922573171
- DantasGCThrompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
- KernanWNOvbiageleBBlackHRGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20144572160223624788967
- LugerSHohmannCKraftPPrescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe – a multicentric evaluationInt J Stroke20149556957524828272
- MoriskyDEAngAKrousel-WoodMWardHPredictive validity of a medication adherence measure for hypertension controlJ Clin Hypertens2008105348354
- MoriskyDEDiMatteoMRImproving the measurement of self-reported medication nonadherence: final responseJ Clin Epidemiol2011643262263
- Krousel-WoodMIslamTWebberLSReRNMoriskyDEMuntnerPNew medication adherence scale versus pharmacy fill rates in seniors with hypertensionAm J Manag Care2009151596619146365
- WangYKongMCKoYPsychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarinThromb Haemost2012108478979522836920
- ClaxtonAJCramerJPierceCA systematic review of the association between dose regimens and medication complianceClin Ther20012381296131011558866
- US Food Drug AdministrationFDA drug safety communication 05/13/2014 on Pradaxa (dabigatran)Silver Spring MDUS Food and Drug Administration Available from: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm397179.htmAccessed April 10, 2015
- LewisWRFonarowGCGrau-SepulvedaMVImprovement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-StrokeAm Heart J2011162469269921982662
- SauerRSauerEMBobingerTAdherence to oral anticoagulation in secondary stroke prevention – the first year of direct oral anticoagulantsJ Stroke Cerebrovasc Dis2015241788225440347
- GliemMHermsenDvan RooijenNHartungHPJanderSSecondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in miceStroke201243123352335723117725